Concepedia

Douglas A. Mayle

DA

5

Publications

383

Citations

5

H-Index

1993

Active since

Affiliations

Eli Lilly (United States)(Current)

Douglas A. Mayle is an author at Eli Lilly (United States) specializing in medicine, physiology, and neuroscience.

Top concepts

MedicinePhysiologyNeurosciencePharmacologySocial SciencesNeuropharmacologyPsychopharmacologyNervous SystemNeurochemistryNeurophysiology

Publications per year

1993–2001

5

Publications

5

LY248686, A New Inhibitor of Serotonin and Norepinephrine Uptake

David T. Wong, Frank P. Bymaster, Douglas A. Mayle et al. · Neuropsychopharmacology · 1993 · 221 citations · Full text

Norepinephrine Uptake, Molecular Pharmacology, Medicine +7

Norfluoxetine Enantiomers as Inhibitors of Serotonin Uptake in Rat Brain

David T. Wong, Frank P. Bymaster, Leroy R. Reid et al. · Neuropsychopharmacology · 1993 · 109 citations · Full text

Serotonin Uptake, Medicine, Psychopharmacology +8

Evaluation of the Erythroid Regenerative Response in Two Different Models of Experimentally Induced Iron Deficiency Anemia

Mary Jo Burkhard, Diane E. Brown, John P. McGrath et al. · Veterinary Clinical Pathology · 2001 · 26 citations · Full text

Nutrition, Iron Deficiency, Oxidative Stress +17

NMDA-sensitive neurons profoundly influence delayed staurosporine-induced apoptosis in rat mixed cortical neuronal cultures

Craig E. Thomas, Douglas A. Mayle · Brain Research · 2000 · 16 citations

Neurophysiology, Physiology, Cell Death +8

Simultaneous Increases of Extracellular Monoamines in Microdialysates from Hypothalamus of Conscious Rats by Duloxetine, a Dual Serotonin and Norepinephrine Uptake Inhibitor

Eric A. Engleman, Kenneth W. Perry, Douglas A. Mayle et al. · Neuropsychopharmacology · 1995 · 11 citations · Full text

Extracellular Monoamines, Psychoactive Drug, Dual Serotonin +14

Rows per page

1–5 of 5